22.7 C
Saturday, July 20, 2024

    Emerging Growth Conference 74 - August 21 & 22 - Register now

    Emerging Growth Conference 69

    April 3 & 4, 2024

    Agenda Wednesday April 3, 2024

    Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes and prediabetes.

    Keynote speaker: Mark Tapsak, PhD, VP of Sensor Technology

    ASP Isotopes Inc. (NASDAQ: ASPI) is a pre-commercial stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries.

    Keynote speaker: Paul Elliot Mann, CEO

    Alpha Cognition Inc. (OTCQB: ACOGF) (CSE: ACOG) is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (“mTBI”), for which there are currently no approved treatment options.

    Keynote speakers: Michael E. McFadden, CEO & Director & Lauren D’Angelo, COO

    SinglePoint Inc. (CBOE: SING) is a renewable energy and sustainable lifestyle company focused on providing environmentally friendly energy efficiencies and healthy living solutions.

    Keynote speaker: Wil Ralston, CEO

    Element79 Gold Corp. (OTC Pink: ELMGF) (CSE: ELEM) is a mining company focused on gold and silver committed to maximizing shareholder value through responsible mining practices and sustainable development of its projects.

    Keynote speaker: James Tworek, CEO

    AseptiScope, Inc., driven to bring forward novel solutions that ensure “Infection Protection for Clinician & Patient.”, is a privately funded San Diego based company founded in 2016 and led by clinical innovation experts, leading medical researchers, and practicing physicians.

    Keynote speaker: Scott W Mader – Founder & CEO

    Ideal Power (NASDAQ: IPWR) is pioneering the development and commercialization of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS/data center, solid-state circuit breaker and other industrial and military applications.

    Keynote speaker: Dan Brdar, President, CEO & Director

    ANGLE, PLC., (OTCQX: ANPCY) (AIM: AGL) is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample.

    Keynote speaker: Andrew Newland, Founder, CEO & Executive Director

    SensTech, Inc. (NASDAQ: SNES), Inventors of ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, is committed to improving the health of the world by humanely managing animal pest populations through fertility control.

    Keynote speaker: Joel L. Fruendt, President, CEO, & Director

    CervoMed Inc. (NASDAQ: CRVO) is a clinical-stage biotechnology company focused on developing treatments for degenerative diseases of the brain.

    Keynote speaker: John Alam, CEO

    Canoo Technologies, Inc. (NASDAQ: GOEV) has developed breakthrough electric vehicles that are reinventing the automotive landscape with their pioneering technologies, unique design, and business model that spans multiple owners across the full lifecycle of the vehicle.

    Keynote speaker: Greg Ethridge, CFO

    Dermata Therapeutics, Inc. (NASDAQ: DRMA) is a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions. 

    Keynote speaker: Gerry Proehl, Founder, Chairman, President & CEO

    OptimumBank Holdings, Inc. (NASDAQ: OPHC) operates as the bank holding company for OptimumBank that provides a range of consumer and commercial banking services to individuals and businesses.

    Keynote speaker: Moishe Gubin, Chairman of the Board.

    Myriad Uranium Corp. (OTCQB: MYRUF) (CSE: M) (FSE: C3Q) is a uranium exploration company with an earnable 75% interest in the Copper Mountain Uranium Project in Wyoming, USA.

    Keynote speaker: Thomas David Lamb, President, CEO, & Director

    Agenda Thursday April 4, 2024

    Strawberry Fields REIT, Inc., (NYSE: STRW) is a self-administered real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare-related properties. 

    Keynote speaker: Moishe Gubin, Chairman, CEO

    Citizens, Inc. (NYSE: CIA) is a diversified financial services company providing life, living benefits and final expense insurance and other financial products to individuals and small businesses in the U.S., Latin America, and Asia.

    Keynote speakers: Gerald W. Shields, Vice Chairman and CEO Jeff Conklin, CFO

    LeddarTech Holdings, Inc. (NASDAQ: LDTC) develops and provides comprehensive AI-based low-level sensor fusion and perception software solutions that enable the deployment of ADAS, autonomous driving (AD) and parking applications.

    Keynote speakers: Frantz Saintellemy – CEOChris Stewart, CFO

    Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. 

    Keynote speaker: Mike Sheikh, Executive Vice President Business Development

    Alpha Seven Therapeutics, Inc. is a private company whose vision is to develop transformative therapies for people wtih brain injury. 

    Keynote speaker: Michael E. McFadden, CEO & Director

    Clearday, Inc. (OTCQX: CLRD) is, with a focus on personalized care and groundbreaking technology, at the forefront of redefining the standards of senior living.

    Keynote speakers: James Walesa, President / CEO, and Dan Policy, Corporate Development

    Shuttle Pharmaceuticals, Inc. (NASDAQ: SHPH) is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy.

    Keynote speaker: Anatoly Dritschilo, MD, CEO & Chairman

    FendX Technologies, Inc. (OTCQB: FDXTF) (CSE: FNDX) is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens.

    Keynote speaker: Carolyn Myers, CEO

    Atacama Resources International, Inc. (OTC Pink: ACRL) has significant mining claims in the greater Kirkland Lake area of Northern Ontario. Metals and minerals under potential exploration include gold, silver, lithium, graphite, cobalt, and diamond.

    Keynote speaker: Greg Praver, Investor Relations

    Regen BioPharma Inc. (OTC Pink: RGBP) is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space.

    Keynote speakers: David Koos, President / CEO, Harry M. Lander, Ph.D. Senior Scientific Consultant, and Annette Marleau, PHD

    Aytu BioPharma (NASDAQ: AYTU) is a pharmaceutical company commercializing a portfolio of commercial prescription therapeutics and consumer health products. 

    Keynote speaker: Joshua Disbrow, Chairman, CEO

    The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.

    Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.

    The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.